A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

WEDNESDAY, June 11, 2025 (HealthDay News) — Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and ...

Hims & Hers has been expanding its presence in the weight management market, with its existing Novo partnership representing ...

Lastly, the researchers observed that while patients who discontinued obesity medications lost significantly less weight ...

A Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

New data indicates that American teenagers are increasingly using the weight-loss drug Wegovy, as confidence in its use for ...

Researchers compared the safety and efficacy of tirzepatide (brand name Zepbound) and semaglutide (brand name Wegovy) in a 72-week clinical trial. The randomized, controlled trial — called ...

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...

Luspatercept showed similar efficacy and safety in real-world settings as observed in the MEDALIST trial for LR-MDS patients post-ESA failure. Transfusion independence was achieved in 44.3% of ...